"桡动脉是仅次于左胸内动脉的第二好导管"。

IF 2.6 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Seminars in Thoracic and Cardiovascular Surgery Pub Date : 2024-10-23 DOI:10.1053/j.semtcvs.2024.07.002

James Tatoulis

引用次数: 0

摘要

越来越多的证据表明，多动脉心肌血管重建术优于单动脉心肌血管重建术。多动脉移植的围手术期效果相当，但长期疗效更佳。将桡动脉（RA）作为继左胸内动脉（LITA）之后的第二条动脉移植物是实现这一目标的最佳且最简单的方法，前提是使用痉挛预防措施并避免竞争性血流。90%以上的患者都有可能使用 RA，它完全可以用作无隐静脉移植（SVG）。RA长而坚固，比右ITA更宽，易于采集和处理，用途广泛，可单独或依次从主动脉或作为Y型或延伸型移植物使用，可到达任何目标。与 LITA 同时采集非常省时。两种 RA 均可使用。RA的短期通畅率非常高，在观察研究和随机试验（RCT）中超过90%。一旦在部署时没有出现技术问题，RA 就能永远保持通畅，通常能保持完美的通畅性。15-20 年的通畅率（包括早期失败）为 87%-90%，心脏不良事件较少，在随机试验中存活率较高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Radial Artery is the Second Best Conduit after the Left Internal Thoracic Artery.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Seminars in Thoracic and Cardiovascular Surgery Medicine-Pulmonary and Respiratory Medicine

CiteScore

5.80

自引率

0.00%

发文量

324

审稿时长

12 days

期刊介绍： Seminars in Thoracic and Cardiovascular Surgery is devoted to providing a forum for cardiothoracic surgeons to disseminate and discuss important new information and to gain insight into unresolved areas of question in the specialty. Each issue presents readers with a selection of original peer-reviewed articles accompanied by editorial commentary from specialists in the field. In addition, readers are offered valuable invited articles: State of Views editorials and Current Readings highlighting the latest contributions on central or controversial issues. Another prized feature is expert roundtable discussions in which experts debate critical questions for cardiothoracic treatment and care. Seminars is an invitation-only publication that receives original submissions transferred ONLY from its sister publication, The Journal of Thoracic and Cardiovascular Surgery. As we continue to expand the reach of the Journal, we will explore the possibility of accepting unsolicited manuscripts in the future.